Articles by ddiadm
Satdarshan (Paul) Singh Monga, M.D.
Jaideep Behari, MD, PhD
Vijay K Yechoor, MD
Mark Schurdak, PhD
PhD in Pharmacology, Baylor College of Medicine My research focus is in the application of Quantitative Systems Pharmacology (QSP) to develop more effective drug discovery strategies that utilize integrated computational and phenotype/function-based analysis. I lead QSP projects addressing neurodegeneration including traumatic brain injury (TBI), Huntington’s Disease (HD), and Alzheimer’s
Andrew Stern, PhD
Novel Cancer Therapies, Tumorigenesis
Lawrence Vernetti, PhD
MS in Toxicology, University of ArizonaPhD in Pharmacology/Toxicology, University of Arizona I spent the first part of my career as a study monitor at AbbVie (formerly Abbott Laboratories) conducting non- GLP and GLP compliant drug safety trials in mice, rats, dogs and non-human primates. During this time I wrote
Andreas Vogt, PhD
PhD, Pharmaceutical Chemistry; B.S. Pharmacy, University of Hamburg, Germany I am a Molecular Pharmacologist with over 20 years of experience in small molecule drug discovery for many diseases including neurodegenerative disease, diabetes, cancer, and organ regeneration, with an emphasis on phenotypic screening. I have been an investigator in over 25
Jan H. Beumer, PharmD, PhD, DAB
John Stewart Maier, PhD MD
12